RxDoctor Payments Data

Brooke Naffziger, DO

Obstetrics & Gynecology · West Columbia, SCNPI 1649412636

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $51,000 of the $69,687 with a category attached, or 73.2%. Applied Medical Resources Corporation accounts for 98.6% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $40,815 and has fallen 79.3% since, to $8,444 in 2025. Among obstetrics & gynecology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$69,687in general payments, 2019–2025

Across 121 payments — averaging $575.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Applied Medical Resources Corporation$69K
  • Baxter Healthcare$161
  • Pfizer$108
  • Channel Medsystems, Inc.$108
  • Sumitomo Pharma America, Inc.$76
  • Exeltis, USA Inc.$67
  • plus $488 from 13 others

What the payments were for

  • Consulting fees$2,0003%
  • Speaking & faculty fees$51,00073%
  • Travel & lodging$14,36821%
  • Food & beverage$2,2263%
  • Education$920%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$69,687 in reported general payments places this provider in the 95th percentile of 673 obstetrics & gynecology providers in South Carolina.

See all obstetrics & gynecology providers in South Carolina

Medicare billing

Part B allowed, 2024
$10,482
Medicare patients
70
Services billed
122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated19$7,207
Estradiol34$1,530
Tolterodine Tartrate ErTolterodine Tartrate22$956
Clobetasol Propionate12$277
Norethindrone24$145

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$108$7,20719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 673 obstetrics & gynecology providers in South Carolina.

Other obstetrics & gynecology in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →